Results 241 to 250 of about 8,132,737 (308)

Diffuse MRI Edema Predicts Relapse in Cerebral Amyloid Angiopathy–Related Inflammation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To identify MRI predictors of relapse and quantify relapse and mortality risk in cerebral amyloid angiopathy–related inflammation (CAA‐RI). A secondary objective was to assess the association between mycophenolate mofetil use and relapse risk. Methods We performed a retrospective cohort study of 36 patients with CAA‐RI treated at the
G. Abbas Kharal, Gowtham Yerneni, Kim J. Griffin, Nicolas Thompson, Ken Uchino, Irene Katzan, Dolora Wisco, Abeer Farrag, Jayashree Sundarajan, Andrew Russman, M. Shazam Hussain   +10 more
wiley   +1 more source

Utility of the APE2 Score as a Diagnostic Tool for Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To retrospectively evaluate the diagnostic performance of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score relative to clinician‐adjudicated autoimmune encephalitis (AE) and the Graus criteria in a tertiary neuroimmunology referral cohort, including antibody‐negative AE.
Bijoya Basu, Sophia F. Damman, Samhitha M. Rai, Hesham Abboud   +3 more
wiley   +1 more source

Qianjinweijingtang Decoction and Its Granule Inhibit Respiratory Syncytial Virus Infection and the Associated Inflammatory Response. [PDF]

Chem Biodivers
Liao CY, Yang ML, Chen ZP, Chen B, Tang YJ, Wang Z, Zhao HN, Deng SH, Ye JH, Liu Z, Chen LF, Li MM.   +11 more
europepmc   +1 more source

Inflammatory Responses [PDF]

, 2006
openaire   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source

Prognostic value of systemic inflammatory response index in patients with bladder cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Mao D, Chen R, Guan F, Sun J, Hua R, Huang J.   +5 more
europepmc   +1 more source

Dysregulation of the miR-4286 in diabetic kidney disease and its role in inflammatory response. [PDF]

Diabetol Metab Syndr
Zhang J, Tang Q, Pu M, Yan L, Chen Y, Wang B.   +5 more
europepmc   +1 more source

Editorial: Deciphering the inflammatory response in colorectal and ovarian cancers. [PDF]

Front Immunol
Bakhashab S, Khan K.
europepmc   +1 more source

Effects of meropenem plus ulinastatin on inflammatory response and complications in patients with severe septic shock. [PDF]

Front Med (Lausanne)
Wu D, Ni W, Zhang X, Liu X.
europepmc   +1 more source